Reuters logo
India's Supreme Court bars Glenmark from selling copies of Merck diabetes drugs-sources
May 15, 2015 / 10:49 AM / 3 years ago

India's Supreme Court bars Glenmark from selling copies of Merck diabetes drugs-sources

MUMBAI, May 15 (Reuters) - India’s Supreme Court has blocked Glenmark Pharmaceuticals Ltd from selling copies of U.S. drugmaker Merck & Co Inc’s diabetes drugs Januvia and Janumet, sources with knowledge of the matter said after a court hearing on Friday.

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

Merck sued Glenmark in 2013 for infringing a patent it has on sitagliptin, the chemical compound in Januvia and Janumet. Glenmark sells the medicines under the brand names Zita and Zita-met. (Reporting by Zeba Siddiqui and Nivedita Bhattacharjee in Mumbai)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below